...
首页> 外文期刊>Journal of Clinical Microbiology >Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis
【24h】

Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis

机译:QIASTAT-DX胃肠道诊断传染性胃肠炎的性能

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Detection and identification of enteropathogens that cause infectious gastroenteritis are essential steps for appropriate patient treatment and effective isolation precautions. Several syndrome-based tests have recently become available, with the gastrointestinal panel (GIP) assay on the QIAstat-Dx as the most recent addition to the syndromic testing landscape. ABSTRACT Detection and identification of enteropathogens that cause infectious gastroenteritis are essential steps for appropriate patient treatment and effective isolation precautions. Several syndrome-based tests have recently become available, with the gastrointestinal panel (GIP) assay on the QIAstat-Dx as the most recent addition to the syndromic testing landscape. The QIAstat-Dx GIP assay offers simultaneous testing for 24 bacterial, viral, and parasitic enteropathogens using a single test that reports the results in 70 min. In this study, we compared the performance of the GIP assay to laboratory-developed real-time PCR assays (LDTs), using 172 prospectively and retrospectively collected fecal samples from patients suspected to have infectious gastroenteritis. The GIP assay detected 97/107 enteropathogens (91%) that were detected by LDTs, and the overall agreement of results increased to 95% when excluding discrepant results with cycle threshold ( C _(T) ) values of &35. Further, the GIP assay detected 42 additional enteropathogens that were not detected, or tested, by LDTs. These included 35 diarrheagenic Escherichia coli targets for which the clinical relevance is unclear for most. The main advantage of the QIAstat-Dx system compared to other syndromic testing systems is the ability to generate C _(T) values that could help with the interpretation of results. However, compared to LDTs, the GIP assay is limited by flexibility and high-throughput testing. In conclusion, the GIP assay offers an easy, sample-to-answer workflow with a rapid detection of the most common enteropathogens and therefore has the potential to direct appropriate therapy and infection control precautions.
机译:导致传染性胃肠炎的肠球病的检测和鉴定是适当患者治疗和有效隔离预防措施的必要步骤。最近有几种基于综合征的测试可用,胃肠道面板(GIP)测定QIASTAT-DX作为综合征测试景观的最新补充。摘要检测和鉴定导致传染性胃肠炎的肠球病是适当的患者治疗和有效隔离预防措施的必要步骤。几个基于综合征的测试最近面世,在QIAstat-DX胃肠面板(GIP)检测作为最近除了综合征测试景观。 QIASTAT-DX GIP测定使用单一试验提供24种细菌,病毒和寄生肠道病同时测试,该试验将结果报告70分钟。在这项研究中,将GIP测定与实验室开发的实时PCR测定(LDTS)的性能进行了比较,并使用疑似患有感染性胃肠炎的患者的患者进行172个粪便样本。通过LDT检测到97/107肠溶病(91%)的GIP测定,并且当循环阈值(C _(T))值的循环阈值排除差异结果时,结果的总协议增加到95%。此外,GIP测定检测到42种额外的肠臭甲型,未检测到或通过LDT检测或测试。这些包括35个腹泻的大肠杆菌靶标,其中临床相关性尚不清楚。 QIASTAT-DX系统与其他综合征测试系统相比的主要优点是能够生成可以帮助解释结果的C _(t)值。然而,与LDT相比,GIP测定受灵活性和高通量测试的限制。总之,GIP测定提供了一种简单的样品 - 回答工作流程,其快速检测最常见的肠道肠,因此有可能直接治疗和感染控制预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号